SUN Pharmaceutical Industries Limited Ornidazole Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Ornidazole Export Records India — #3 Exporter, 30 Shipments, $1.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Ornidazole

India Pharmaceutical Trade Intelligence

$17.7M249 Suppliers83 CountriesHS 30049099

ExportsIndia → TANZANIA28.1%India → FRANCE19.7%

SUN Pharmaceutical Industries Limited — Ornidazole Exporter #3 | $1.4M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Ornidazole Exporter Profile

Indian Pharmaceutical Exporter · #3 for Ornidazole · $1.4M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #3 Indian exporter of Ornidazole with $1.4M in export value and 30 verified shipments. SUN Pharmaceutical Industries Limited holds a 8.1% market share in Ornidazole exports across 7 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Ornidazole Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Ornidazole export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Ornidazole?

Country	Value	Shipments	Share
MYANMAR	$521.1K	12	49.8%
LITHUANIA	$185.9K	5	17.8%
KAZAKISTAN	$100.0K	2	9.6%
SRI LANKA	$79.6K	6	7.6%
KENYA

Who Are the Top Buyers of Ornidazole from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
M/S. JDS CO., LTD.	MYANMAR	$188.0K	4
M/S	MYANMAR	$133.2K	4
UAB VILNIAUS TRANZITAS	LITHUANIA	$83.7K	2
UAB VILNIAUS TRANZITAS,	LITHUANIA	$52.2K	2
FREE LINE DISTRIBTUION LLP	KAZAKISTAN	$50.0K	1
JDS CO LIMITED ADDRESS NO 9 YAWMINGYI	MYANMAR	$50.0K	1
MS JDS CO LTD	MYANMAR	$50.0K	1
MS JDS CO LIMITED	MYANMAR	$50.0K	1
KFK MEDSERVICE PLUS	KAZAKISTAN	$50.0K	1
MS UAB VILNIAUS TRANZITAS,	LITHUANIA	$50.0K	1

SUN Pharmaceutical Industries Limited supplies Ornidazole to 23 buyers globally. The largest buyer is M/S. JDS CO., LTD. (MYANMAR), followed by M/S (MYANMAR) and UAB VILNIAUS TRANZITAS (LITHUANIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Ornidazole Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
DAZOLIC TABLETS [Ornidazole film coated	$135.9K	4
DAZOLIC TABS. (Ornidazole Tablets, 500mg)	$133.2K	4
DAZOLIC TABS (ORNIDAZOLE TABLETS 500MG)	$50.0K	1
DAZOLIC TABS(ORNIDAZOLE TABLETS 500MG)PA	$50.0K	1
DAZOLIC TABS. (Ornidazole Tablets, 500mg	$50.0K	1
DAZOLIC 500 TABLETS EACH TABLET CONTAINSORNIDAZOLE EQ TO 500MG PACK 05 01 10	$50.0K	1
DAZOLIC TABS. ORNIDAZOLE TABLETS 500MG	$50.0K	1
DAZOLIC TABS. Ornidazole Tablets, 500mg PACK : 10*10 Batch : JME0558A	$50.0K	1
DAZOLIC TABS. Ornidazole Tablets 500mg PACK : 10*10 Batch : JME0808A	$50.0K	1
DAZOLIC TAB 500MG CONTAINS ORNIDAZOLE SAP CODE:1149327 BNO:JME0935A MFD:10/2023EXP:09/2026	$50.0K	1

SUN Pharmaceutical Industries Limited exports 25 distinct Ornidazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DAZOLIC TABLETS [Ornidazole film coated with 4 shipments worth $135.9K.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Ornidazole Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	MICRO LABS LIMITED	$4.0M	181	15	$21.9K
3	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$1.4M	30	7	$47.7K
1	LINCOLN PHARMACEUTICALS LTD	$700.0K	14	5	$50.0K
4	KUSUM HEALTHCARE PRIVATE LIMITED	$504.7K	49	11	$10.3K

SUN Pharmaceutical Industries Limited ranks #3 among 249 Indian Ornidazole exporters. Average shipment value of $47.7K compared to the market average of $35.6K. The closest competitors by value are MICRO LABS LIMITED and LINCOLN PHARMACEUTICALS LTD.

Which Indian Ports Ship Ornidazole Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	118	10.0%
JNPT/ NHAVA SHEVA SEA	77	6.6%
DELHI AIR CARGO ACC (INDEL4)	75	6.4%
DELHI AIR	69	5.9%
SAHAR AIR CARGO ACC (INBOM4)	66	5.6%
SAHAR AIR	60	5.1%
JNPT	58	4.9%
BANGALORE ACC (INBLR4)	53	4.5%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Ornidazole Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ornidazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 32 individual customs records matching SUN Pharmaceutical Industries Limited exporting Ornidazole, covering 25 formulations to 7 countries via 23 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 83+ countries, 439+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ornidazole

Ornidazole

SUN Pharmaceutical Industries Limited — Ornidazole Exporter Profile

SUN Pharmaceutical Industries Limited — Ornidazole Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Ornidazole?

Who Are the Top Buyers of Ornidazole from SUN Pharmaceutical Industries Limited?

What Is India's Total Ornidazole Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Ornidazole Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Ornidazole Exporters?

What Ornidazole Formulations Does SUN Pharmaceutical Industries Limited Export?

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Ornidazole Exporters?

Which Indian Ports Ship Ornidazole Exports?

Ornidazole — Export Intelligence Video

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Ornidazole Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ornidazole Export Data from SUN Pharmaceutical Industries Limited

Ornidazole Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source